Journals / Çocuk Dergisi / 2022 / Cilt: 22 - Sayı: 2

Risk Factors for Persistent Pulmonary Hypertension of the Newborn and Determining the Clinical Prognosis

Yenidoğanlarda Persistan Pulmoner Hipertansiyon Risk Faktörleri, Klinik ve Prognozun Belirlenmesi

Pages
110–116
Publication Date
2022-09-09
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mortality and mortality-related morbidities are thought to be able to be decreased by defining the risk factors for developing PPHN.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Persistent pulmonary hypertension of the newborn (PPHN) is a serious clinical condition that developed through the persistence of high pulmonary vascular resistance during the transition period and results in severe morbidities and mortality.
📊
Key Findings & Data:Materials and Method: This retrospective study was conducted between January 2017 and January 2019.
💡
Conclusion & Impact:Mortality and mortality-related morbidities are thought to be able to be decreased by defining the risk factors for developing PPHN.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:persistan pulmoner hipertansiyon · yenidoğan · preterm

Abstract

Objective: Persistent pulmonary hypertension of the newborn (PPHN) is a serious clinical condition that developed through the persistence of high pulmonary vascular resistance during the transition period and results in severe morbidities and mortality. This study aims to determine the risk factors for developing PPHN and to evaluate the prognosis, morbidities, and mortality. Materials and Method: This retrospective study was conducted between January 2017 and January 2019. Hospital records of infants who needed neonatal intensive care were evaluated retrospectively in terms of etiological causes of PPHN, clinical prognosis of neonates, morbidities, and mortality rates. Results: A total of 29,650 infants were born during the 2-year study period, 920 of whom were admitted to a neonatal intensive care unit, of which 50 developed PPHN. Of the infants who developed PPHN, 66% were preterm and 52% were female. The most common etiology related to developing PPHN is congenital pneumonia (65%) in term infants and respiratory distress syndrome (100%) in preterm infants. The second most common etiology is perinatal asphyxia for both term and preterm infants. Morbidities such as patent ductus arteriosus, intraventricular hemorrhage, necrotizing enterocolitis, and bronchopulmonary dysplasia were higher in the preterm group, with mortality rates also being significantly higher in preterm infants. Conclusion: Persistent pulmonary hypertension of the newborn is a serious clinical condition that may result in high neonatal mortality even when appropriate cardiopulmonary support is given. Mortality and mortality-related morbidities are thought to be able to be decreased by defining the risk factors for developing PPHN.

Özet

Amaç: Yenidoğanın persistan pulmoner hipertansiyonu (PPHN) geçiş döneminde pulmoner vasküler direncin yüksek kalması sonucu gelişen önemli morbidite ve mortalite ile sonlanabilen ciddi bir klinik durumdur. Bu çalışmada PPHN tanısıyla izlenen yenidoğan bebeklerde risk faktörlerinin belirlenmesi, klinik prognozun, mortalite ve morbiditelerin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Retrospektif gözlemsel bu çalışmada Ocak 2017-Ocak 2019 tarihileri arasında Yenidoğan Yoğun Bakım Ünitesinde (YYBÜ) PPHN tanısıyla izlenen bebeklerin verileri hastane kayıtlarından incelenmiş, PPHN etiyolojisi, bebeklerin klinik bulguları, morbiditeler ve mortalite değerlendirilmiştir. Bulgular: İki senelik çalışma periyodunda toplam 29.650 bebek dünyaya geldi, bebeklerin 920’si YYBÜ’de yatırıldı ve 50 bebekte PPHN saptandı. PPHN gelişen olguların %66’sı prematüre ve %52’si kız idi. PPHN gelişimi ile ilişkilendirilen en sık etiyolojik faktör term bebeklerde konjenital pnömoni (%65) iken, preterm bebeklerde respiratuar distres sendromu (%100) idi. Her iki grupta da en sık ikinci etiyolojik faktör perinatal asfiksi idi. Patent duktus arteriyozus, intraventriküler kanama, nekrotizan enterokolit ve bronkopulmoner displazi gibi morbiditeler PPHN gelişen preterm bebeklerde daha sık görülürken, mortalite oranı da preterm grupta daha yüksek bulundu. Tartışma: Persistan pulmoner hipertansiyon, uygun kardiyorespiratuvar destek ve güncel tedavilere rağmen yüksek neonatal mortaliteye sahip ciddi bir durumdur. Pulmoner hipertansiyon gelişimi ve mortalite üzerine etkili risk faktörlerinin belirlenmesi ile mortalite ve ilişkili morbiditelerin azaltılabileceği düşünülmektedir.

🔖

Cite This Article

YAŞA, B., DİNCER, E., BABAYİĞİT, A., SEMERCİ, S. Y., MEMUR, Ş., SAĞLAM, Ö., GÖNEN, İ., BÜKER, H. S. C., ÖZKAN, S., BORNAUN, H., ÖZTARHAN, K., ÇETİNKAYA, M. (2022). Risk Factors for Persistent Pulmonary Hypertension of the Newborn and Determining the Clinical Prognosis. Çocuk Dergisi, Cilt: 22 - Sayı: 2, 110–116. https://ajindex.com/articles/715322

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Steinhorn RH. Neonatal Pulmonary Hypertension. Pediatr Crit Care Med 2010;11(2 Suppl):S79-S84. google scholar 2. Hooper SB, Te Pas AB, Lang J, et al. Cardiovascular transition at birth: a physiological sequence. Pediatr Res 2015;77:608-14. google scholar 3. Aktas SY, Diniz G, Ortac R, Aktas EÖ. Pulmonary hypertension grading in the neonate: Pediatric autopsy series compared with etiology of lung disease. Aegean Pathology Journal 2004;1:76-80. google scholar 4. Jain A, McNamara PJ. Persistent pulmonary hypertension of the hewborn: Advances in diagnosis and treatment. Semin Fetal Neonatal Med 2015;20(4):262-71. google scholar 5. Lakshminrusimha S, Keszler M. Persistent Pulmonary Hypertension of the Newborn. Neoreviews 2015;16;e680. google scholar 6. de Boode WP, Singh Y, Molnar Z, Schubert U, Savoia M, Sehgal A et al. Application of neonatologist performed echocardiography in the assessment and management of persistent pulmonary hypertension of the newborn. Pediatric Research 2018;84:68-77. google scholar 7. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CC, Korones SB, Stevenson DK et al. Persistant pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatr 2000;105:14-20. google scholar 8. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000;136:611-7. google scholar 9. Ozkan H, Erdeve O, Kutman HGK. Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment. Turk Pediatri Ars 2018;53(S1):S45-S54. Doi: 10.5152/TurkPediatriArs.2018.01806 google scholar 10. Köksal N, Aygün C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars 2018; 53(S1):S76-87. google scholar 11. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163(7):1723-9.doi: 10.1164/ajrccm.163.7. 2011060 google scholar 12. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33(1):179-201. doi: 10.1016/s0031-3955(16) 34975-6 google scholar 13. Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe JJ, editor. Neurology of the newborn. 5th edition. Philadelphia: Elsevier; 2008. Pp. 517588. google scholar 14. International Committee for